Physician profile
Gurmeet Singh
NPI 1417927732
$9,207.98
in general payments reported to CMS, 2019-2025
39 companies · $1,384 in 2025
The $1,384 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $630 · 2021: $1,435 · 2022: $1,460 · 2023: $1,615 · 2024: $2,083 · 2025: $1,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,875 · Travel and Lodging: $155 · Education: $52.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,874.70 |
| Travel and Lodging | $154.67 |
| Education | $52.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,299.15 | 2019-2025 | |
| Pfizer INC. | $1,036.98 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $786.10 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $578.86 | 2019-2025 | Farxiga, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $568.89 | 2020-2025 | Camzyos, Eliquis |
| Amgen INC. | $560.58 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $559.51 | 2022-2025 | Turbohawk, Linq II, Hawkone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $531.86 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $416.18 | 2021-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $380.24 | 2019-2025 | Lifevest |
| Esperion Therapeutics, INC. | $349.71 | 2020-2024 | Nexletol |
| Abiomed | $347.03 | 2025 | |
| Novo Nordisk INC | $276.50 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $269.72 | 2024-2025 | |
| Akcea Therapeutics, INC. | $201.69 | 2019-2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $173.90 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Mitraclip |
| Boston Scientific Corporation | $156.00 | 2021-2022 | |
| Amarin Pharma, INC. | $85.25 | 2019-2021 | |
| Canon Medical Systems USA, INC. | $52.00 | 2025 | Ct Scanner |
| Regeneron Healthcare Solutions, INC. | $51.19 | 2020-2023 | Evkeeza |
| Medtronic Vascular, INC. | $47.38 | 2020 | |
| Cook Medical LLC | $45.00 | 2019 | |
| Agepha Pharma Fz LLC | $43.25 | 2024 | Lodoco |
| Alnylam Pharmaceuticals INC. | $41.39 | 2025 | |
| Edwards Lifesciences Corporation | $39.81 | 2020-2021 | |
| Heartflow, INC. | $36.16 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $33.84 | 2022-2023 | Assure Wcd |
| Bridgebio Pharma, INC. | $30.31 | 2025 | Attruby |
| Bardy Diagnostics, INC. | $26.20 | 2020 | |
| Siemens Medical Solutions USA, INC. | $23.69 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Lundbeck LLC | $23.06 | 2020 | |
| Genzyme Corporation | $21.96 | 2023 | |
| Irhythm Technologies, INC. | $21.22 | 2024 | Zio Xt Patch, Zio Monitor |
| Tactile Systems Technology INC | $18.00 | 2025 | Nimbl, Flexitouch Plus |
| Biotronik INC. | $17.66 | 2020 | |
| Cardiva Medical, INC. | $16.40 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $16.02 | 2019 | |
| Covidien LP | $14.00 | 2019 | |
| Daxor Corporation | $11.29 | 2024 | Bva-100 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gurmeet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.